Ropinirole Hydrochloride Patent Expiration

Ropinirole Hydrochloride is used for treating Parkinson's syndrome. It was first introduced by Glaxosmithkline Llc in its drug Requip on Sep 19, 1997. Another drug containing Ropinirole Hydrochloride is Requip Xl. 19 different companies have introduced drugs containing Ropinirole Hydrochloride.


Ropinirole Hydrochloride Patents

Given below is the list of patents protecting Ropinirole Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Requip Xl US7927624 Hydrophilic/lipophilic polymeric matrix dosage formulation Dec 02, 2021

(Expired)

Glaxosmithkline Llc
Requip Xl US8303986 Hydrophilic/lipophilic polymeric matrix dosage formulation Apr 12, 2021

(Expired)

Glaxosmithkline Llc



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ropinirole Hydrochloride's patents.

Given below is the list recent legal activities going on the following patents of Ropinirole Hydrochloride.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 24 Jun, 2024 US8303986
Expire Patent 22 May, 2023 US7927624
Maintenance Fee Reminder Mailed 05 Dec, 2022 US7927624
Payment of Maintenance Fee, 8th Year, Large Entity 21 Apr, 2020 US8303986
Payment of Maintenance Fee, 8th Year, Large Entity 09 Oct, 2018 US7927624
Recordation of Patent Grant Mailed 06 Nov, 2012 US8303986
Patent Issue Date Used in PTA Calculation 06 Nov, 2012 US8303986
Email Notification 18 Oct, 2012 US8303986
Issue Notification Mailed 17 Oct, 2012 US8303986
Dispatch to FDC 02 Oct, 2012 US8303986


Ropinirole Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ropinirole Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Ropinirole Hydrochloride. The first generic version for Ropinirole Hydrochloride was by Cosette Pharmaceuticals Inc and was approved on May 5, 2008. And the latest generic version is by Prinston Pharmaceutical Inc and was approved on May 11, 2022.

Given below is the list of companies who have filed for Ropinirole Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.25MG BASE

tablet Prescription ORAL AB Feb 28, 2017
EQ 1MG BASE

tablet Prescription ORAL AB Feb 28, 2017
EQ 2MG BASE

tablet Prescription ORAL AB Feb 28, 2017
EQ 3MG BASE

tablet Prescription ORAL AB Feb 28, 2017
EQ 4MG BASE

tablet Prescription ORAL AB Feb 28, 2017
EQ 5MG BASE

tablet Prescription ORAL AB Feb 28, 2017
EQ 0.5MG BASE

tablet Prescription ORAL AB Feb 28, 2017





2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 8MG BASE

tablet, extended release Prescription ORAL AB May 17, 2012
EQ 6MG BASE

tablet, extended release Prescription ORAL AB May 17, 2012
EQ 4MG BASE

tablet, extended release Prescription ORAL AB May 17, 2012
EQ 2MG BASE

tablet, extended release Prescription ORAL AB May 17, 2012
EQ 12MG BASE

tablet, extended release Prescription ORAL AB May 17, 2012


Manufacturing Plant Locations
New

Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.

Country City Firm Name
United States
Elizabeth Actavis Elizabeth LLC, A Company of Teva





3. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE

tablet, extended release Prescription ORAL AB Apr 22, 2013
EQ 4MG BASE

tablet, extended release Prescription ORAL AB Apr 22, 2013
EQ 6MG BASE

tablet, extended release Prescription ORAL AB Apr 22, 2013
EQ 12MG BASE

tablet, extended release Prescription ORAL AB Apr 22, 2013
EQ 8MG BASE

tablet, extended release Prescription ORAL AB Apr 22, 2013


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Vadodara Alembic Pharmaceuticals, Ltd
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)





4. ALEMBIC LTD

Alembic Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE

tablet Prescription ORAL AB Mar 24, 2010
EQ 5MG BASE

tablet Prescription ORAL AB Mar 24, 2010
EQ 0.25MG BASE

tablet Prescription ORAL AB Mar 24, 2010
EQ 0.5MG BASE

tablet Prescription ORAL AB Mar 24, 2010
EQ 1MG BASE

tablet Prescription ORAL AB Mar 24, 2010
EQ 2MG BASE

tablet Prescription ORAL AB Mar 24, 2010
EQ 3MG BASE

tablet Prescription ORAL AB Mar 24, 2010





5. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 10 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE

tablet, extended release Prescription ORAL AB Aug 27, 2012
EQ 0.25MG BASE

tablet Prescription ORAL AB May 29, 2008
EQ 0.5MG BASE

tablet Prescription ORAL AB May 29, 2008
EQ 1MG BASE

tablet Prescription ORAL AB May 29, 2008
EQ 2MG BASE

tablet, extended release Prescription ORAL AB Aug 27, 2012
EQ 3MG BASE

tablet Prescription ORAL AB May 29, 2008
EQ 5MG BASE

tablet Prescription ORAL AB May 29, 2008
EQ 6MG BASE

tablet, extended release Prescription ORAL AB Aug 27, 2012
EQ 8MG BASE

tablet, extended release Prescription ORAL AB Aug 27, 2012
EQ 12MG BASE

tablet, extended release Prescription ORAL AB Aug 27, 2012





6. COSETTE

Cosette Pharmaceuticals Inc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.5MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 0.25MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 1MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 2MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 3MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 4MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 5MG BASE

tablet Discontinued ORAL N/A May 19, 2008


Manufacturing Plant Locations
New

Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.

Country City Firm Name
United States
Lincolnton Cosette Pharmaceuticals NC Laboratories, LLC
South Plainfield Cosette Pharmaceuticals, Inc.





7. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE

(reference standard)

tablet, extended release Prescription ORAL AB Jun 6, 2012
EQ 4MG BASE

tablet, extended release Prescription ORAL AB Jun 6, 2012
EQ 6MG BASE

tablet, extended release Prescription ORAL AB Jun 6, 2012
EQ 8MG BASE

tablet, extended release Prescription ORAL AB Jun 6, 2012
EQ 12MG BASE

tablet, extended release Prescription ORAL AB Jun 6, 2012





8. EPIC PHARMA LLC

Epic Pharma Llc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE

tablet Discontinued ORAL N/A May 20, 2008
EQ 2MG BASE

tablet Discontinued ORAL N/A May 20, 2008
EQ 3MG BASE

tablet Discontinued ORAL N/A May 20, 2008
EQ 4MG BASE

tablet Discontinued ORAL N/A May 20, 2008
EQ 5MG BASE

tablet Discontinued ORAL N/A May 20, 2008
EQ 0.25MG BASE

tablet Discontinued ORAL N/A May 20, 2008
EQ 0.5MG BASE

tablet Discontinued ORAL N/A May 20, 2008





9. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.25MG BASE

tablet Prescription ORAL AB Feb 25, 2010
EQ 0.5MG BASE

tablet Prescription ORAL AB Feb 25, 2010
EQ 1MG BASE

tablet Prescription ORAL AB Feb 25, 2010
EQ 2MG BASE

tablet Prescription ORAL AB Feb 25, 2010
EQ 3MG BASE

tablet Prescription ORAL AB Feb 25, 2010
EQ 4MG BASE

tablet Prescription ORAL AB Feb 25, 2010
EQ 5MG BASE

tablet Prescription ORAL AB Feb 25, 2010





10. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.25MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 0.5MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 1MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 2MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 3MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 4MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 5MG BASE

tablet Discontinued ORAL N/A May 19, 2008


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





11. MLV

Mlv Pharma Llc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Mlv.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE

tablet Prescription ORAL AB Feb 7, 2012
EQ 4MG BASE

tablet Prescription ORAL AB Feb 7, 2012
EQ 3MG BASE

tablet Prescription ORAL AB Feb 7, 2012
EQ 2MG BASE

tablet Prescription ORAL AB Feb 7, 2012
EQ 1MG BASE

tablet Prescription ORAL AB Feb 7, 2012
EQ 0.5MG BASE

tablet Prescription ORAL AB Feb 7, 2012
EQ 0.25MG BASE

tablet Prescription ORAL AB Feb 7, 2012





12. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 6 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 3MG BASE

tablet, extended release Discontinued ORAL N/A Oct 15, 2012
EQ 4MG BASE

tablet, extended release Discontinued ORAL N/A Oct 15, 2012
EQ 6MG BASE

tablet, extended release Discontinued ORAL N/A Oct 15, 2012
EQ 8MG BASE

tablet, extended release Discontinued ORAL N/A Oct 15, 2012
EQ 12MG BASE

tablet, extended release Discontinued ORAL N/A Oct 15, 2012
EQ 2MG BASE

tablet, extended release Discontinued ORAL N/A Oct 15, 2012





13. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.25MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 0.5MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 1MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 2MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 3MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 4MG BASE

tablet Discontinued ORAL N/A May 5, 2008
EQ 5MG BASE

tablet Discontinued ORAL N/A May 19, 2008





14. ORBION PHARMS

Orbion Pharmaceuticals Private Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Orbion Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.25MG BASE

tablet Prescription ORAL AB Nov 28, 2012
EQ 0.5MG BASE

tablet Prescription ORAL AB Nov 28, 2012
EQ 1MG BASE

tablet Prescription ORAL AB Nov 28, 2012
EQ 2MG BASE

tablet Prescription ORAL AB Nov 28, 2012
EQ 3MG BASE

tablet Prescription ORAL AB Nov 28, 2012
EQ 4MG BASE

tablet Prescription ORAL AB Nov 28, 2012
EQ 5MG BASE

tablet Prescription ORAL AB Nov 28, 2012





15. PRINSTON INC

Prinston Pharmaceutical Inc has filed for 10 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Prinston Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 0.25MG BASE

(reference standard)

tablet Prescription ORAL AB May 5, 2008
EQ 0.5MG BASE

tablet Prescription ORAL AB May 5, 2008
EQ 1MG BASE

tablet Prescription ORAL AB May 5, 2008
EQ 2MG BASE

tablet, extended release Prescription ORAL AB May 11, 2022
EQ 3MG BASE

tablet Prescription ORAL AB May 5, 2008
EQ 4MG BASE

tablet, extended release Prescription ORAL AB May 11, 2022
EQ 5MG BASE

tablet Prescription ORAL AB Jul 11, 2008
EQ 6MG BASE

tablet, extended release Prescription ORAL AB May 11, 2022
EQ 8MG BASE

tablet, extended release Prescription ORAL AB May 11, 2022
EQ 12MG BASE

tablet, extended release Prescription ORAL AB May 11, 2022





16. SANDOZ INC

Sandoz Inc has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE

tablet, extended release Prescription ORAL AB Jun 6, 2012
EQ 4MG BASE

tablet, extended release Prescription ORAL AB Jun 6, 2012
EQ 6MG BASE

tablet, extended release Prescription ORAL AB Jun 6, 2012
EQ 8MG BASE

tablet, extended release Prescription ORAL AB Jun 6, 2012
EQ 12MG BASE

tablet, extended release Prescription ORAL AB Jun 6, 2012


Manufacturing Plant Locations
New

Sandoz Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sandoz Inc as present at those locations.

Country City Firm Name
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated





17. WATSON LABS INC

Watson Laboratories Inc has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE

tablet, extended release Discontinued ORAL N/A Jun 6, 2012
EQ 4MG BASE

tablet, extended release Discontinued ORAL N/A Jun 6, 2012
EQ 6MG BASE

tablet, extended release Discontinued ORAL N/A Jun 6, 2012
EQ 8MG BASE

tablet, extended release Discontinued ORAL N/A Jun 6, 2012
EQ 12MG BASE

tablet, extended release Discontinued ORAL N/A Jun 6, 2012





18. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE

tablet Prescription ORAL AB Jun 1, 2009
EQ 2MG BASE

tablet Prescription ORAL AB Jun 1, 2009
EQ 1MG BASE

tablet Prescription ORAL AB Jun 1, 2009
EQ 0.5MG BASE

tablet Prescription ORAL AB Jun 1, 2009
EQ 0.25MG BASE

tablet Prescription ORAL AB Jun 1, 2009
EQ 5MG BASE

tablet Prescription ORAL AB Jun 1, 2009
EQ 3MG BASE

tablet Prescription ORAL AB Jun 1, 2009


Manufacturing Plant Locations
New

Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.

Country City Firm Name
India
Matoda Zydus Lifesciences Limited
Ahmedabad Zydus Lifesciences Limited
District Solan Zydus Lifesciences Limited
Moraiya, Ahmedabad Zydus Lifesciences Limited
Ankleshwar Zydus Lifesciences Limited
Jarod Zydus Lifesciences Limited
Thane Zydus Lifesciences Limited
Ahmedabad ZYDUS LIFESCIENCES LIMITED
Dabhasa Zydus Lifesciences Limited